1Collucci WS. Molecular and cellular mechanisms of myocardial[J]. Am J Cardiol, 1997,80(1): 15L-25L.
2Bristow MR. β-adrenergic receptor blockade in chronic heart failure[J]. Circulation, 2000,101(6): 558-569.
3Bropht JN, Joseph Ⅰ, Rouleau JL. β-blocker in congestive heart failure-A Bayesian meta-analysis[J]. Ann Intern Med,2001,134(4): 550-560.
4Anonymous. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intrvention Trial in Congestive Heart Failure (MERIT-HF)[J].Lancot, 1999,353(9169) :2001-2007.
5Anonymous. The cardiac insufficiency bissoprolol study Ⅱ (CIBIS-Ⅱ):a randomized trial[J]. Lancet, 1999,353(1):9-13.
6Whorlow SL, Knm H. Meta-analysis of effect of β-blocker therapy on mortality in patients with NEW YORK heart Assocation class Ⅳ chronic congestive heart failure[J]. Am J Cardiol,2000,86(8):886-889.
7Eichhom EI, Bristow MR. Medican therapy can improve the biological properties the chronically failing heart: a new era in the treatment of heart failure[J]. Circulation, 1996,94(10): 2258-2296.
8Hall SA, Cigarroa CG, Marcoux L, et al. Time course of improvement in left ventricular function. mass, and geometry in patients with congestive heart failure treated with β-adrenergic blockade[J]. J Am Coil Cardiol,1995,25(8):1154-1161.
2Meissner A. Recent developments in beta - blockers and anesthesia. Current Opinion in Anesthesiology ,2005, 18:339-343.
3VanDenKerkhof EG, Milne B, Parlow JL. Knowledge and practice regarding prophylactic periopcrative beta blockade in patients undergoing noncardiac surgery. Anesth Analg, 2003, 96: 1558-1565.
4Mangano DT, Browner WS, Hollenberg M, et al. Association of periopcrative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery. N Engl J Med, 1990, 323 : 1781- 1788.
5Badner NH, Knill RL, Brown JE, et al. Myocardial Infarction after noncardiac surgery. Anesthesiology, 1998, 88:572-578.
6Fleisher LA. Eagle KA. Lowering caMiac risk in noncardiac surgery. N Engl J Med, 2001, 345:1677-1682.
7Lindenauer PK, Pekow P, Wang K, et al. Perioperative beta -blocker therapy anti mortality after major noncardiac surgery. N Engl J Med, 2005, 353:349-361.
8Mangano DT. Layug EL, Wallace A, et at. Effect of atenotot on mortalitv and cardiovascular morbidity after noncardiac surgery. N Engl J Med, 1996, 335 : 17 t 3-1720.
9Poldermans D, Boersma E, Bax J J, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high - risk patients undergoing vascular surgery. N Engl J Med, 1999, 341:1789-1794.
